Resistance Exercise Training For Improved Muscle Insulin Sensitivity

Overview

About this study

The purpose of this research is to uncover the underlying mechanisms of resistance exercise training benefits on glucose metabolism and insulin sensitivity in muscle.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria: 

  • Young-middle aged (age 30-50)

 

Exclusion criteria:

  • The presence of any of the following is an exclusion for the study:

    •  Active coronary artery disease or heart failure.

    • Participation in a structured exercise program > 1 day/week.

    • A known medical condition that in the judgment of the investigator might interfere with the completion

  • Of the protocol such as the following examples:

    • Abnormal liver function test results (Transaminase >2 times the upper limit of normal)

    • Abnormal renal function test results (calculated GFR <60 mL/min/1.73m2

    • If on antihypertensive, thyroid, anti-depressant or lipid lowering medication, lack of stability on the medication for the past 2 months prior to enrollment in the study

    • Uncontrolled thyroid disease (TSH undetectable or >10 mlU/L); testing required within three months prior to admission for subjects with a goiter, positive antibodies, or who are on thyroid hormone replacement, and within one year otherwise

    • Abuse of alcohol or recreational drugs

    • Active tobacco usage

    • Infectious process not anticipated to resolve prior to study procedures (e.g. meningitis, pneumonia, osteomyelitis).

    • Uncontrolled arterial hypertension (Resting diastolic blood pressure >90 mmHg and/or systolic blood pressure >160 mmHg) at the time of screening

    • A recent injury to body or limb, muscular disorder, use of any medication, any carcinogenic disease, or other significant medical disorder if that injury, medication or disease in the judgment of the investigator will affect the completion of the protocol

    •  Active pregnancy

    • Menopause (defined as absence of menstruation for 12 consecutive months)

  • Restrictions on Use of Other Drugs or Treatments:

    • Any other medication believed to be a contraindication to the subject’s participation.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 11/22/2024. Questions regarding updates should be directed to the study team contact.
 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Mark Pataky, Ph.D., M.S.

Contact us for the latest status

More information

Publications

Publications are currently not available
.
CLS-20601449

Mayo Clinic Footer